Join a Legacy of Innovation 125 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
We are currently seeking a Global Development Information Management Intern for a year (June 2025 – May 2026). This full-time position works for approximately 37.5 hours per week.
Responsibilities: Support running GenAI project which would more expand next year and working under Janie.
Support running Data Governance work under Satyaki as he has done similar for this year.
Education/Experience:
Expected skills: Basic Word, PPT, Excel skills. Prefer any NLP based tools, AI tools.
Qualified candidates must currently be enrolled in an accredited graduate program with a concentration in Biology, Pharmacy, Programming, Data Analytics, AI Engineer, Data Science, machine learnings or related field. Prior experience in a corporate business environment is preferred; experience in the pharmaceutical industry is a plus.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. All qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
Similar Jobs
What We Do
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.” For more information, please visit www.daiichisankyo.com.
